344 related articles for article (PubMed ID: 23481121)
1. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
3. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.
Dalamaga M; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
Clin Biochem; 2013 May; 46(7-8):584-90. PubMed ID: 23321342
[TBL] [Abstract][Full Text] [Related]
4. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
5. Adipocytokine resistin and breast cancer risk.
Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
[TBL] [Abstract][Full Text] [Related]
6. Predictors of insulin resistance in patients with obesity: a pilot study.
Stepien M; Stepien A; Wlazel RN; Paradowski M; Rizzo M; Banach M; Rysz J
Angiology; 2014 Jan; 65(1):22-30. PubMed ID: 23267236
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
[TBL] [Abstract][Full Text] [Related]
8. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
[TBL] [Abstract][Full Text] [Related]
9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
10. Could serum visfatin be a potential biomarker for postmenopausal breast cancer?
Dalamaga M; Archondakis S; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
Maturitas; 2012 Mar; 71(3):301-8. PubMed ID: 22261365
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
12. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B
Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948
[TBL] [Abstract][Full Text] [Related]
14. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
[TBL] [Abstract][Full Text] [Related]
15. Dietary glycemic index/load and peripheral adipokines and inflammatory markers in elderly subjects at high cardiovascular risk.
Bulló M; Casas R; Portillo MP; Basora J; Estruch R; García-Arellano A; Lasa A; Juanola-Falgarona M; Arós F; Salas-Salvadó J
Nutr Metab Cardiovasc Dis; 2013 May; 23(5):443-50. PubMed ID: 22209741
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
20. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
